Company news

Alterity Therapeutics Ltd. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

New York Academy of Sciences Symposium Discusses PBT2

March 30, 2016

New benchmark test to assess HD patients in clincial trials

March 30, 2016

Prana Updates Progress on PBT2 Trials

March 30, 2016

Pranas PBT2 Reverses Memory Loss in Normal Aging

March 30, 2016

Prana Provides Update on Clinical Trials for Alzheimers

March 30, 2016

Prana completes PBT2 dosing in IMAGINE AD Trial

March 30, 2016

Parkinsons UK Awards GBP150,000 to Study Pranas PBT434

March 30, 2016

Appendix 4E Preliminary Final Report and Statutory Accounts

March 30, 2016

Prana Alzheimers disease Development Program update

March 30, 2016

Appendix 4D Half Yearly Report and Accounts

February 25, 2016

Appendix 4E and Annual Report 2015

February 11, 2016

Trial presented at World Congress on Huntington`s Disease

February 10, 2016

Share Purchase Plan 2013 Offer Document

February 10, 2016

Safety Outcomes of Alzheimers IMAGINE Extension Trial

February 10, 2016

Response to ASX price query

February 10, 2016

Prana`s PBT2 presented at HDSA National Convention

February 10, 2016

Pranas Parkinsons drug meets development milestone

February 10, 2016

Prana secures key PBT2 patents in the US and Europe

February 10, 2016

Prana secures key PBT2 patent in Japan

February 10, 2016

Prana`s Co-Founding Scientist Awarded Prestigious Fellowship

February 10, 2016

Prana receives approval for open label extension study in AD

February 10, 2016

Prana Receives Approval For Alzheimer`s Trial

February 10, 2016

Prana Provides Update on PBT2 AD Extension trial

February 10, 2016

Prana plans to advance Alzheimers clinical trial

February 10, 2016

Prana Announces Successful Phase 2 Results in HD Trial

February 10, 2016

Prana announces preliminary results of Alzheimers Trial

February 10, 2016

Prana announces $6.8 million R&D refund

February 10, 2016

Prana Announces A$6.0 Million Capital Raising

February 10, 2016

PBT2 recommended for orphan designation in Europe

February 10, 2016

New PBT2 data in 2010 Hot Topics Session

February 10, 2016

New Analysis of Clinical Trial published in Journal of AD

February 10, 2016

Journal of Huntingtons Disease Publishes Benefits of PBT2

February 10, 2016

Government Grant to Study effect of PBT2 in the ageing brain

February 10, 2016

FDA End-of Phase 2 Status Update

February 10, 2016

FDA Approval to Commence Huntington`s Disease Clinical Trial

February 10, 2016

Approval of PBT2 Orphan Designation for Huntingtons Disease

February 10, 2016

Appendix 4E & Preliminary Final Report

February 10, 2016

Appendix 4D for the Half Year Ended 31 December 2009

February 10, 2016

Appendix 4D

February 10, 2016

← Newer news releases

Decks

The 5 newest of 47 decks. Every deck is listed under its year.